| Literature DB >> 33536616 |
Direna Alonso-Curbelo1, Yu-Jui Ho1, Cassandra Burdziak2,3, Jesper L V Maag4, John P Morris1, Rohit Chandwani5,6,7, Hsuan-An Chen1,8, Kaloyan M Tsanov1, Francisco M Barriga1, Wei Luan1, Nilgun Tasdemir1, Geulah Livshits1, Elham Azizi2, Jaeyoung Chun2,9, John E Wilkinson10, Linas Mazutis2,9, Steven D Leach5,11,12, Richard Koche4, Dana Pe'er2, Scott W Lowe13,14.
Abstract
Tissue damage increases the risk of cancer through poorly understood mechanisms1. In mouse models of pancreatic cancer, pancreatitis associated with tissue injury collaborates with activating mutations in the Kras oncogene to markedly accelerate the formation of early neoplastic lesions and, ultimately, adenocarcinoma2,3. Here, by integrating genomics, single-cell chromatin assays and spatiotemporally controlled functional perturbations in autochthonous mouse models, we show that the combination of Kras mutation and tissue damage promotes a unique chromatin state in the pancreatic epithelium that distinguishes neoplastic transformation from normal regeneration and is selected for throughout malignant evolution. This cancer-associated epigenetic state emerges within 48 hours of pancreatic injury, and involves an 'acinar-to-neoplasia' chromatin switch that contributes to the early dysregulation of genes that define human pancreatic cancer. Among the factors that are most rapidly activated after tissue damage in the pre-malignant pancreatic epithelium is the alarmin cytokine interleukin 33, which recapitulates the effects of injury in cooperating with mutant Kras to unleash the epigenetic remodelling program of early neoplasia and neoplastic transformation. Collectively, our study demonstrates how gene-environment interactions can rapidly produce gene-regulatory programs that dictate early neoplastic commitment, and provides a molecular framework for understanding the interplay between genetic and environmental cues in the initiation of cancer.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33536616 PMCID: PMC8482641 DOI: 10.1038/s41586-020-03147-x
Source DB: PubMed Journal: Nature ISSN: 0028-0836 Impact factor: 49.962